Inhibition of herpes simplex virus type 1 helicase-primase by (dichloroanilino)purines and -pyrimidines

J Med Chem. 1995 May 12;38(10):1820-5. doi: 10.1021/jm00010a027.

Abstract

Herpes simplex virus type 1 (HSV1) encodes a heterotrimeric helicase-primase comprised of the products of three of the seven DNA replication-specific genes. Several dihalo-substituted derivatives of N2-phenylguanines and 2-anilinoadenines weakly inhibited the intrinsic DNA-dependent NTPase activity of the HSV1 helicase-primase, and these compounds inhibited the DNA-unwinding activity of the enzyme. The primase activity of the enzyme was strongly inhibited by 3,4- and 3,5-dichloroanilino derivatives of adenine and 2-aminopyrimidines. These compounds and nucleoside analogs of 2-(3,5-dichloroanilino)purines inhibited viral DNA synthesis in HSV1-infected HeLa cells in culture but also inhibited cellular DNA synthesis, likely as a result of inhibition of cellular primase and/or DNA polymerases.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aniline Compounds
  • Antiviral Agents / pharmacology
  • Cell Division / drug effects
  • DNA Helicases / antagonists & inhibitors*
  • DNA Primase
  • DNA, Viral / biosynthesis
  • DNA, Viral / drug effects
  • HeLa Cells
  • Herpesvirus 1, Human / enzymology*
  • Herpesvirus 1, Human / genetics
  • Humans
  • Purines / pharmacology*
  • Pyrimidines / pharmacology*
  • RNA Nucleotidyltransferases / antagonists & inhibitors*

Substances

  • Aniline Compounds
  • Antiviral Agents
  • DNA, Viral
  • Purines
  • Pyrimidines
  • DNA Primase
  • RNA Nucleotidyltransferases
  • DNA Helicases